您的位置:阿仪网 > 生物试剂/抗体/细胞 > 生化试剂 > 培养基 > 厦门慧嘉生物科技有限公司 > 产品展示 > 细胞因子 > PROSPEC > HIV-2 gp-36 (390-702 a.a.)/重组艾滋病毒2 gp36(390-702)

联系我们

联系人:陈先生

点击查看联系方式

产品展示

HIV-2 gp-36 (390-702 a.a.)/重组艾滋病毒2 gp36(390-702)

HIV-2 gp-36 (390-702 a.a.)/重组艾滋病毒2 gp36(390-702)

点击次数:246

价格:¥电议

更新日期:2026/8/24 23:18:11

生 产 地:美洲

产品型号:

简单介绍:HIV-2 gp-36 (390-702 a.a.)/重组艾滋病毒2 gp36(390-702)

商家名片
陈**
联系我时,请说明是阿仪网看到的,谢谢!
  • 电话: 05*******891
  • 手机: 18******628
  • 微信:
  • 交换名片后展示联系方式 → →
相关标签:HIV-2,gp-36,(390-702,a.a.),重组艾滋病毒2,gp36(

详细内容

慧嘉生物您实验身边的好伙伴

为客户提供“最高品质的产品”和“最优质的服务”

AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec
欢迎广大客户咨询,另有大量宣传海报和小礼品赠送。
网站:www..com
Q Q:

HIV-2 gp-36 (390⁻⁷02 a.a.)/重组艾滋病毒2 gp36(390⁻⁷02)

产品编号:HIV-139
产品规格:100μg/500μg/1mg
Introduction HIV-1 and HIV-2 appear to package their RNA differently. HIV-1 binds to any appropriate RNA whereas HIV-2 preferentially binds to mRNA which creates the Gag protein itself. This means that HIV-1 is better able to mutate. HIV-2 is transmitted in the same ways as HIV-1: Through exposure to bodily fluids such as blood, semen, tears and vaginal fluids. Immunodeficiency develops more slowly with HIV-2.
HIV-2 is less infectious in the early stages of the virus than with HIV-1.
The infectiousness of HIV-2 increases as the virus progresses.
Major differences include reduced pathogenicity of HIV-2 relative to HIV-1, enhanced immune control of HIV-2 infection and often some degree of CD4-independence. Despite considerable sequence and phenotypic differences between HIV-1 and 2 envelopes, structurally they are quite similar. Both membrane-anchored proteins eventually form the 6-helix bundles from the N-terminal and C-terminal regions of the ectodomain, which is common to many viral and cellular fusion proteins and which seems to drive fusion.
HIV-1 gp41 helical regions can form more stable 6-helix bundles than HIV-2 gp41 helical regions however HIV-2 fusion occurs at a lower threshold temperature (25°C), does not require Ca2+ in the medium, is insensitive to treatment of target cells with cytochalasin B, and is not affected by target membrane glycosphingolipid composition.
Description HIV-2 gp36 34 kDa recombinant- contains the sequence of HIV-2 envelope immunodominant regions gp36, amino acids 390⁻⁷02. The protein is fused to beta-galactosidase (114 kDa) at N-terminus.
Source Escherichia Coli.
Physical Appearance Sterile filtered colorless clear solution.
Formulation 0.01M Na2CO3, 0.01M Na3EDTA, 0.014 M?-mercaptoethanol, 0.02% Sarcosyl.
Purity Greater than 95.0% as determined by HPLC analysis and SDS-PAGE.
Stability Protein should be stored at 4°C.
Refrigerate Upon arrival. DO NOT FREEZE.
Specificity Immunoreactive with all sera of HIV-2 infected individuals.
Applications HIV-2 gp-36 antigen in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems.
Usage ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

HIV-2,gp-36,(390-702,a.a.),重组艾滋病毒2,gp36(

采购记录

优质供应

相关文章

  • 友情链接
  • 热词推荐
在线咨询5分钟应答

提交